[{"address1": "1751 River Run", "address2": "Suite 400", "city": "Fort Worth", "state": "TX", "zip": "76107", "country": "United States", "phone": "(817) 887-8455", "website": "https://actuatetherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of cancers. The company's lead product candidate is Elraglusib Injection, a novel glycogen synthase kinase-3 inhibitor to treat metastatic pancreatic ductal adenocarcinoma. It also develops Elraglusib for the treatment of Ewing sarcoma, metastatic melanoma, and colorectal cancer. The company was formerly known as Apotheca Therapeutics, Inc. and changed its name to Actuate Therapeutics, Inc. in October 2015. The company was incorporated in 2015 and is based in Fort Worth, Texas.", "fullTimeEmployees": 10, "companyOfficers": [{"maxAge": 1, "name": "Mr. Daniel M. Schmitt", "age": 61, "title": "CEO, President & Director", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 520000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew P. Mazar Ph.D.", "age": 61, "title": "Co-Founder & COO", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 607500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Alan  Kozikowski Ph.D.", "age": 72, "title": "Scientific Founder and Advisor", "yearBorn": 1951, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul J. Lytle CPA", "age": 55, "title": "Chief Financial Officer", "yearBorn": 1968, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 8.15, "open": 8.18, "dayLow": 8.06, "dayHigh": 8.2399, "regularMarketPreviousClose": 8.15, "regularMarketOpen": 8.18, "regularMarketDayLow": 8.06, "regularMarketDayHigh": 8.2399, "volume": 9544, "regularMarketVolume": 9544, "averageVolume": 42493, "averageVolume10days": 37040, "averageDailyVolume10Day": 37040, "bid": 8.04, "ask": 8.39, "bidSize": 100, "askSize": 100, "marketCap": 155759536, "fiftyTwoWeekLow": 7.33, "fiftyTwoWeekHigh": 10.162, "fiftyDayAverage": 8.357, "twoHundredDayAverage": 8.357, "currency": "USD", "enterpriseValue": 111986440, "floatShares": 546301, "sharesOutstanding": 19111600, "sharesShort": 4290, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.0002, "heldPercentInsiders": 0.19097, "heldPercentInstitutions": 0.52212, "shortRatio": 0.06, "impliedSharesOutstanding": 19111600, "bookValue": -63.743, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -27770424, "trailingEps": -1.85, "52WeekChange": -0.048199773, "SandP52WeekChange": 0.24014747, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "ACTU", "underlyingSymbol": "ACTU", "shortName": "Actuate Therapeutics, Inc.", "longName": "Actuate Therapeutics, Inc. Common stock", "firstTradeDateEpochUtc": 1723555800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "a36078c9-3fe4-3046-b959-8723608de23f", "messageBoardId": "finmb_313171219", "gmtOffSetMilliseconds": -14400000, "currentPrice": 8.15, "recommendationKey": "none", "totalCash": 2068307, "totalCashPerShare": 1.223, "totalDebt": 5000000, "quickRatio": 0.14, "currentRatio": 0.149, "operatingCashflow": -21513908, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]